The creator of CRISPR babies is flirting again with infamy, this time through a mysterious alliance with an Internet-savvy ...

Investors interested in the Genomics and Synthetic Biology theme may consider adding these three stocks to their portfolio - Intellia Therapeutics (NTLA), uniQure (QURE) and Verve Therapeutics (VERV).

For centuries, yeast has been an essential ingredient in the production of wine and bread. Scientists are able to adjust ...

The Therapeutic BCG Vaccine Market offers growth opportunities through expanding applications beyond TB prevention, including bladder cancer and autoimmune diseases. Advances in biotechnology, ...

Synthetic biology has grown exponentially in less than a decade, with CRISPR gene-editing as the ... living through the early stages of the ‘biotech century’, as economic and social theorist ...

U.S. technology is set to “do very well” under the administration of President Trump, and one sector in particular, said Ark ...

BURLINGAME, CA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- Biotechnology Market is estimated to be valued at USD 1,034.63 Bn in 2025 and is expected to reach USD 2,330.47 Bn in 2032, exhibiting ...

To remain relevant in an interconnected ecosystem, biopharma must go beyond optimising yesterday’s markets and begin ...

Initial experimental results showed that the tool helped modify the target gene in more than 90% of Escherichia coli colonies ...

STAT reporters chat about the mood in the gene editing field, M&A deals in biotech, and leadership changes at Novo Nordisk.

In the latest episode of Touching Base, we discuss big news in CRISPR along with updates in the business side of biotech.